An early stage trial found that a new drug combination can reduce the rates of treatment-related diarrhea in patients with breast cancer. Preventative treatment with the combination of loperamide and ...
– Combination regimen is approved for use in the second-line treatment setting and beyond – “Historically, patients with HER2-positive metastatic colorectal cancer who have progressed following ...
Conducted by Jaguar Health subsidiary Napo Pharmaceuticals in collaboration with Puma Biotechnology, the study provides scientific rationale for the use of crofelemer in treating cancer patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback